Visit booth 1147 to learn more about LumiThera, Inc.
LumiThera is a medical device company focused on diagnosing, treating and monitoring ocular disease and damage including dry AMD, a leading cause of blindness in adults over 65.
Our flagship product, the Valeda® Light Delivery System, uses multiwavelength photobiomodulation to treat dry AMD. Valeda is CE Marked in the EU and available in select countries in Latin America. Valeda is not approved by the FDA.
AdaptDx Pro® dark adaptation functional testing technology enables eye care professionals to detect and monitor AMD three years before clinical presentation. AdaptDx Pro is listed on the FDA’s Establishment Registration & Device Listing.
Diopsys ERG and VEP systems help eye care professionals analyze the entire pathway for visual and neuro-visual disorders. VEP is FDA-cleared. ERG and VEP are available in select countries outside of the US.
LumiThera’s AMD Excellence Program® provides customer implementation, training, best practices and ongoing support across all brands.
For more information on Valeda, visit www.lumithera.com. AdaptDx Pro and Diopsys ERG/VEP systems are available separately through LumiThera Diagnostics, Inc. and Diopsys, Inc.
Brands: Valeda Light Delivery System
AdaptDx Pro
Diopsys ERG & VEP